DAS 28

DAS28 is a composite score using 28 tender/swollen joint counts, a patient global measure, and ESR/CRP to quantify rheumatoid arthritis disease activity.

Indications for Use

Used to quantify RA inflammatory activity, guide treat‑to‑target decisions, and determine remission/low‑disease‑activity status for therapy adjustment. Clinically useful for tracking response, predicting functional decline and orthopedic surgery risk (higher DAS28 categories markedly increase long‑term surgery incidence 1 [Level II evidence]), and lowering cardiovascular risk when maintained ≤3.2 (HR 0.65 2 [Level II evidence]).

Insights & Cautions

Start by noting it can miss active disease, especially in feet/ankles, because only 28 joints are assessed; this causes false “remission” in up to 15% of paired assessments 1 [Level II evidence].

  • CRP version underestimates activity versus ESR, inflating remission/LDA by 4–26% 2 [Level II evidence].
  • Not interchangeable with DAS28-ESR; criteria differ 3 [Level II evidence].
  • Less stringent for remission than SDAI/Boolean; may leave residual synovitis 4 [Level III evidence].